CBDBYCBDBYOTC
Loading
EBITDA Over TimeContracting
Percentile Rank20
3Y CAGR-57.0%
5Y CAGR-47.6%
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

3Y CAGR
-57.0%/yr
Annual compound
5Y CAGR
-47.6%/yr
Recent deceleration
Percentile
P20
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 yr
Consecutive growthContracting
PeriodValueYoY Change
TTM$150.49M+38.0%
2024$109.07M-95.0%
2023$2.18B+15.2%
2022$1.90B-17.8%
2021$2.31B-39.5%
2020$3.81B-